Levamisole: A dangerous new cocaine adulterant

Clinical Pharmacology and Therapeutics

Volumn 88, Issue 3, 2010, Pages 408-411

  Chang, A ^a   Osterloh, J ^b   Thomas, J ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOREX; COCAINE; DRUG METABOLITE; FLUOROURACIL; LEVAMISOLE; REXAMINO; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE GRANULOCYTIC LEUKEMIA; ADJUVANT CHEMOTHERAPY; AGRANULOCYTOSIS; AMYOTROPHIC LATERAL SCLEROSIS; BREAST CANCER; COLON CANCER; COLORECTAL CANCER; DRUG ACTIVITY; DRUG INDICATION; DRUG METABOLISM; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; HEPATITIS B; HUMAN; MELANOMA; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RHEUMATOID ARTHRITIS; SHORT SURVEY; ULCERATIVE COLITIS;

ADJUVANTS, IMMUNOLOGIC; AGRANULOCYTOSIS; ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; DRUG CONTAMINATION; HUMANS; LEVAMISOLE; PRODUCT RECALLS AND WITHDRAWALS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77955919604     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.156     Document Type: Short Survey

References (30)

1. Centers for Disease Control and prevention (CDC). Agranulocytosis associated with cocaine use\four states, March 2008-November 2009. MMWR Morb. Mortal. Wkly. Rep. 58, 1381-1385 (2009).
2. Shannon, M. Clinical toxicity of cocaine adulterants. Ann. Emerg. Med. 17, 1243-1247 (1988).
3. Coomber, R. The adulteration of drugs: what dealers do to illicit drugs, and what they think is done to them. Addict. Res. Theory 5, 297-306 (1997).
4. Schauben, J.L. Adulterants and substitutes. Emerg. Med. Clin. North Am. 8, 595-611 (1990).
5. Brunt, T.M., Rigter, S., Hoek, J., Vogels, N., Van Dijk, P. & Niesink, R.J. An analysis of cocaine powder in the Netherlands: content and health hazards due to adulterants. Addiction 104, 798-805 (2009).
6. Boddiger, D. Fentanyl-laced street drugs "kill hundreds". Lancet 368, 569-570 (2006).
7. Centers for Disease Control and prevention (CDC). Atypical reactions associated with heroin use-fve states, January-April 2005. MMWR Morb. Mortal. Wkly. Rep. 54, 793-796 (2005).
8. Zhang, J.X., Zhang, D.A.M. & Han, X.G. Identifcation of impurities and statistical classifcation of methamphetamine hydrochloride drugs seized in China. Forensic Sci. Int. 182, 13-19 (2008).
9. Langston, J.W., Ballard, P., tetrud, J.W. & Irwin, I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980 (1983).
10. John, F. Casale, E.M.C., & Hays, P.A. Identifcation of levamisole impurities found in illicit cocaine exhibits. Microgram 6, 3-5 (2008).
11. Zhu, N.Y., Legatt, D.F. & Turner, A.R. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann. Intern. Med. 150, 287-289 (2009).
12. Wiens, M.O., Son, W.K., Ross, C., Hayden, M. & Carleton, B. Cases: Cocaine adulterant linked to neutropenia. CMAJ 182, 57-59 (2010).
13. Knowles, L. et al. Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduct. J. 6, 30 (2009).
14. Thompson, J.S. et al. Studies on levamisole-induced agranulocytosis. Blood 56, 388-396 (1980).
15. Hodinka, L., Géher, P., Merétey, K., Gyódi, E.K., Petrányi, G.G. & Bozsóky, S. Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies. Int. Arch. Allergy Appl. Immunol. 65, 460-464 (1981).
16. Goldin, A., Chirigos, M.A., Macdonald, J.S., Fefer, A. & Mihich, E. Biologic-response modifers and adjuvant chemotherapy: consideration of selected preclinical investigations in relation to clinical potential. Recent Results Cancer Res. 80, 351-356 (1982).
17. Martin, R.J. Modes of action of anthelmintic drugs. Vet. J. 154, 11-34 (1997).
18. Raymon, L.P. & Isenschmid, D.S. Letter to the editor: the possible role of levamisole in illicit cocaine preparations. J. Anal. Toxicol. 33, 620-622 (2009).
19. Ford, E.J. & Evans, J. Combined efect of slow release levamisole and prolate on acetylcholinesterase activity in cattle. Vet. Rec. 120, 579-580 (1987).
20. Maietti, S., Castagna, F., Molin, L., Ferrara, S.D. & Traldi, P. Cocaine adulterants used as marker compounds. J. Mass Spectrom. 44, 1124-1126 (2009).
21. Ho, E.N. et al. Aminorex and rexamino as metabolites of levamisole in the horse. Anal. Chim. Acta 638, 58-68 (2009).
22. Ioannides-Demos, L.L., Proietto, J., Tonkin, A.M. & McNeil, J.J. safety of drug therapies used for weight loss and treatment of obesity. Drug Saf. 29, 277-302 (2006).
23. Bunker, C.F., Johnson, M., Gibb, J.W., Bush, L.G. & Hanson, G.R. Neurochemical efects of an acute treatment with 4-methylaminorex: a new stimulant of abuse. Eur. J. Pharmacol. 180, 103-111 (1990).
24. Meririnne, E., Kajos, M., Kankaanpää, A., Koistinen, M., Kiianmaa, K. & Seppälä, T. Rewarding properties of the stereoisomers of 4-methylaminorex: involvement of the dopamine system. Pharmacol. Biochem. Behav. 81, 715-724 (2005).
25. Russell, B.R., Beresford, R.A., Schmierer, D.M., McNaughton, N. & Clark, C.R. stimulus properties of some analogues of 4-methylaminorex. Pharmacol. Biochem. Behav. 51, 375-378 (1995).
26. Young, R. & Glennon, R.A. Cocaine-stimulus generalization to two new designer drugs: methcathinone and 4-methylaminorex. Pharmacol. Biochem. Behav. 45, 229-231 (1993).
27. Davis, F.T. & Brewster, M.E. A fatality involving U4Euh, a cyclic derivative of phenylpropanolamine. J. Forensic Sci. 33, 549-553 (1988).
28. Gaine, S.P., Rubin, L.J., Kmetzo, J.J., Palevsky, H.I. & Traill, T.A. Recreational use of aminorex and pulmonary hypertension. Chest 118, 1496-1497 (2000).
29. Barker, S.A. The formation of aminorex in racehorses following levamisole administration. A quantitative and chiral analysis following synthetic aminorex or levamisole administration vs. aminorex-positive samples from the feld: a preliminary report. J. Vet. Pharmacol. Ther. 32, 160-166 (2009).
30. Young, R. Aminorex produces stimulus efects similar to amphetamine and unlike those of fenfuramine. Pharmacol. Biochem. Behav. 42, 175-178 (1992).